MAXCYTE, INC. - 10-Q Filing

MaxCyte, Inc. reports third quarter 2026 financial results including updates on cell engineering technology segment and subsequent debt financing events.

SEC EDGAR ·

Tickers: $MXCT

Read the full article at SEC EDGAR

More Regulatory news